PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 27(3): 340-346 2007
© 2007 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ammirati, A. L.
Right arrow Articles by Canziani, M. E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ammirati, A. L.
Right arrow Articles by Canziani, M. E. F.

PERITONEAL DIALYSIS IN LATIN AMERICA

THE PROGRESSION AND IMPACT OF VASCULAR CALCIFICATION IN PERITONEAL DIALYSIS PATIENTS

Adriano Luiz Ammirati1, Maria Aparecida Dalboni1, Miguel Cendoroglo1, Sérgio Antonio Draibe1, Raul D. Santos2, Márcio Miname2 and Maria Eugênia F. Canziani1

1 Nephrology Division, Federal University of São Paulo; 2 The Lipid Clinic of the Heart Institute (InCor), University of São Paulo, São Paulo, Brazil

Correspondence to: M.E.F. Canziani, Nephrology Division, Federal University of São Paulo, 282 Pedro de Toledo Street, São Paulo 04039-000 Brazil.
dialisefor{at}uol.com.br

{diamondsuit} Background: Progression of coronary artery calcification (CAC) has been described in hemodialysis patients, and severe CAC has been associated with the occurrence of cardiovascular events in this population. Little information is available regarding peritoneal patients.

{diamondsuit} Aim: To prospectively evaluate peritoneal dialysis patients in order to identify the variables associated with the rate of CAC progression, as well as to determine the impact that baseline CAC has on clinical outcomes over a 1-year follow-up period.

{diamondsuit} Methods: Using multislice coronary tomography, calcium scores were estimated at baseline and after 12 months in 49 peritoneal dialysis patients. Patients with and without CAC progression were compared with respect to clinical characteristics and biochemical variables, including lipid profile, parameters of mineral metabolism, and markers of inflammation. Cardiovascular events, hospitalizations, and all-cause mortality were recorded.

{diamondsuit} Results: At baseline, 29 patients (59%) presented CAC and a median calcium score of 234.7 (range 10.3-2351) Agatston units. Progression of CAC was observed in 13 patients (43%) who, in comparison with those presenting no CAC progression, were older, presented higher baseline calcium scores, and had higher mean glucose levels, lower mean high density lipoprotein cholesterol levels, and more months using low calcium peritoneal solution. We also observed a trend toward more often presenting with a history of hypertension, exhibiting more hyperphosphatemic and hyperglycemic events, and having lower albumin levels. In multiple logistic regression, only baseline calcium score was independently associated with progression of CAC. A shorter cardiovascular event-free time and a trend toward lower survival rates were observed in the group with CAC. Hospitalization event-free time did not differ between the groups.

{diamondsuit} Conclusion: Determining CAC provides important prognostic data in peritoneal dialysis patients. Baseline calcium score and disturbances in glucose, mineral, and lipid metabolism were indicative of higher risk of CAC progression in this population.

KEY WORDS: KEY WORDS:; Vascular calcification; mortality; cardiovascular disease; atherosclerosis; coronary tomography; inflammation; mineral metabolism.

Received 8 January 2007; accepted 5 February 2007.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Jaroszynski, E. Czekajska-Chechab, A. Drelich-Zbroja, T. Zapolski, and A. Ksiazek
Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T
Nephrol. Dial. Transplant., October 31, 2008; (2008) gfn581v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2007 by Multimed Inc.